1
|
Lum SH, Albert MH, Gilbert P, Sirait T, Algeri M, Muratori R, Fournier B, Laberko A, Karakukcu M, Unal E, Ayas MF, Yadav SP, Fisgin T, Elfeky R, Fernandes JF, Faraci M, Cole T, Schulz AS, Meisel R, Zecca M, Ifversen M, Biffi A, Diana JS, Vallée TC, Giardino S, Ersoy GZ, Moshous D, Gennery AR, Balashov D, Bonfim CMS, Locatelli F, Lankester AC, Neven B, Slatter MA. Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity. Blood 2024:blood.2024024038. [PMID: 38669631 DOI: 10.1182/blood.2024024038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2024] [Revised: 03/27/2024] [Accepted: 04/17/2024] [Indexed: 04/28/2024] Open
Abstract
HLA-mismatched transplants with either in vitro depletion of CD3+TCRαβ/CD19 (TCRαβ) cells or in vivo T-cell depletion using post-transplant cyclophosphamide (PTCY) have been increasingly used for patients with inborn errors of immunity (IEI). We performed a retrospective multicenter study via the EBMT registry on 306 children with IEI undergoing first transplant between 2010-2019 from an HLA-mismatched donor using TCRαβ (n=167) or PTCY (n=139). Median age at HSCT was 1.2 years (range, 0.03-19.6 years). The 3-year overall survival (OS) was 78% (95% confidence interval (CI), 71-84%) after TCRαβ and 66% (57-74%) after PTCY (p=0.013). Pre-HSCT morbidity score (hazard ratio (HR) 2.27, 1.07-4.80, p=0.032) and non-Busulfan/Treosulfan conditioning (HR 3.12, 1.98-4.92, p<0.001) were the only independent predictors of unfavorable OS. The 3-year event-free survival (EFS) was 58% (50-66%) after TCRαβ and 57% (48-66%) after PTCY (p=0.804). Cumulative incidence of severe acute GvHD was higher after PTCY (15%, 9-21%) than TCRαβ (6%, 2-9%, p=0.007), with no difference in chronic GvHD (PTCY, 11%, 6-17%; TCRαβ, 7%, 3-11%, p=0.173). The 3-year GvHD-free EFS was 53% (44-61%) after TCRαβ and 41% (32-50%) after PTCY (p=0.080). PTCY had significantly higher rates of veno-occlusive disease (14.4% versus TCRαβ 4.9%, p=0.009), acute kidney injury (12.7% versus 4.6%, p=0.032) and pulmonary complications (38.2% versus 24.1%, p=0.017). Adenoviraemia (18.3% versus PTCY 8.0%, p=0.015), primary graft failure (10%, versus 5%, p=0.048), and second HSCT (17.4% versus 7.9%, p=0.023) were significantly higher in TCRαβ. In conclusion, this study demonstrates that both approaches are suitable options in IEI patients, although characterized by different advantages and outcomes.
Collapse
Affiliation(s)
- Su Han Lum
- Newcastle University, Newcastle upon Tyne, United Kingdom
| | - Michael H Albert
- Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany
| | | | | | | | - Rafaella Muratori
- Hospital de Cli-nicas da Universidade Federal do Parana, Curitiba, Brazil
| | | | - Alexandra Laberko
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation
| | | | - Ekrem Unal
- Erciyes University, Pediatric Hematology Oncology, Kayseri, Turkey
| | - Mouhab F Ayas
- King Faisal Specialist Hospital, Riyadh, Saudi Arabia
| | | | - Tunc Fisgin
- Altinbas University Faculty of Medicine Medical Park Bahcelievler Hospital, Istanbul, Turkey
| | - Reem Elfeky
- Great Ormond Street (GOS) Hospital for Children NHS Foundation Trust, University College London GOS Institute of Child Health, and NIHR GOSH BRC, London, United Kingdom
| | - Juliana Folloni Fernandes
- ITACI/Instituto da Crianca - Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil
| | | | | | | | - Roland Meisel
- Center for Child & Adolescent Health, Heinrich-Heine-University, Duesseldorf, Germany
| | - Marco Zecca
- Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
| | | | | | - Jean-Sebastien Diana
- Hopital Universitaire Necker-Enfants Malades, Assistance Publique-Hopitaux de Paris, Paris, France
| | - Tanja C Vallée
- Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
| | | | - Gizem Zengin Ersoy
- Altinbas University Faculty of Medicine Medical Park Bahcelievler Hospital, Istanbul, Turkey
| | | | | | - Dmitry Balashov
- Dmitriy Rogachev National Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation
| | - Carmem M S Bonfim
- Hospital Pequeno Principe/Pele Pequeno Príncipe Research Institute, Curitiba, Brazil
| | - Franco Locatelli
- Bambino Gesù Children's Hospital, Catholic University of Sacred Heart, Rome, Italy
| | | | - Bénédicte Neven
- Hospital Necker-Enfants Malades, Assistance Publique-Hospitaux de Paris, INSERM, paris, France
| | - Mary A Slatter
- Newcastle upon Tyne NHS Foundation trust, Newcastle Upon Tyne, United Kingdom
| |
Collapse
|
2
|
Yadav SP, Raj R, Uppuluri R, Choudhary D, Doval D, Dua V, Bhat S, Kharya G, Patil R, Bansal S, M D, Mehdi I, Mathews V, Abraham A, George B. Outcome of allogeneic stem cell transplant for Fanconi anemia in India. Pediatr Hematol Oncol 2024; 41:169-171. [PMID: 38013455 DOI: 10.1080/08880018.2023.2286971] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Accepted: 11/11/2023] [Indexed: 11/29/2023]
Affiliation(s)
| | - Revathi Raj
- Department of Pediatric Hemato-Oncology & BMT, Apollo Hospital, Chennai, India
| | - Ramya Uppuluri
- Department of Pediatric Hemato-Oncology & BMT, Apollo Hospital, Chennai, India
| | - Dharma Choudhary
- Department of Hematology & BMT, BLK Super specialty Hospital, Delhi, India
| | - Divya Doval
- Department of Hematology & BMT, BLK Super specialty Hospital, Delhi, India
| | - Vikas Dua
- Pediatric Hemato-oncology & BMT, Fortis Memorial Research Institute, Gurgaon, India
| | - Sunil Bhat
- Pediatric Hemato-Oncology & BMT, Narayana Hyrudalaya, Bengaluru, India
| | - Gaurav Kharya
- Pediatric Hemato-Oncology & BMT, Indraprastha Apollo Hospital, Delhi, India
| | | | - Shweta Bansal
- Department of Pediatric Hemato-Oncology, LTMGH, Sion Hospital, Mumbai, India
| | - Deendayalan M
- Pediatric Hemato-Oncology & BMT, Rela Institute of Medical Sciences, Chennai, India
| | - Intezar Mehdi
- Pediatric Hemato-Oncology & BMT, HCG Hospital, Bengaluru, India
| | - Vikram Mathews
- Department of Hematology, Christian Medical College, Vellore, India
| | - Aby Abraham
- Department of Hematology, Christian Medical College, Vellore, India
| | - Biju George
- Department of Hematology, Christian Medical College, Vellore, India
| |
Collapse
|
3
|
Kumar V, Singh CS, Bakshi S, Kumar S, Yadav SP, Al-Zamani ZAS, Kumar P, Singh U, Meena KK, Bunkar DS, Paswan VK. Physicochemical and bioactive constituents, microbial counts, and color components of spray-dried Syzygium cumini L. pulp powder stored in different packaging materials under two controlled environmental conditions. Front Nutr 2023; 10:1258884. [PMID: 37860034 PMCID: PMC10582985 DOI: 10.3389/fnut.2023.1258884] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2023] [Accepted: 09/11/2023] [Indexed: 10/21/2023] Open
Abstract
Currently, the demand for functional food items that impart health benefits has been rising. Blackberry (Syzygium cumini L.) fruit has high anthocyanin content and other functional attributes. However, this seasonal fruit is highly perishable, and a large proportion of it goes unharvested and wasted worldwide. Spray drying of the fruit pulp can impart improved shelf life, ensuring long-term availability for consumers to exploit its health benefits. The storage quality varies according to the type of packaging material and the storage environment. Therefore, in this study, the shelf life span of the spray-dried Syzygium cumini L. pulp powder (SSCPP) was investigated during 6 months of storage under three types of packaging materials (i.e., polystyrene, metalized polyester, and 4-ply laminates) in a low-temperature environmental (LTE) and at ambient environmental conditions. The physicochemical stability of bioactive principles (TPC and TAC), microbial counts, and color components were analyzed at 0, 2, 4, and 6 months of storage. There was a significant gradual loss of dispersibility and solubility with an increase in flowability, bulk density, and wettability during the entire storage period for all three packaging materials. The TSS, pH, TPC, TAC, and microbial counts decreased in the SSCPP both at ambient and LTE conditions during the study. Among all the packaging materials, the 4-ply laminate was found to be the most appropriate and safe for storage of spray-dried SCPP at LTE conditions.
Collapse
Affiliation(s)
- Vishal Kumar
- Department of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi, India
| | - Chandra Shekhar Singh
- Department of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi, India
| | - Shiva Bakshi
- Department of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi, India
| | - Sudhir Kumar
- Department of Food Technology, School of Life Sciences and Biotechnology, CSJMU, Kanpur, India
| | - Satya Prakash Yadav
- Department of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi, India
| | - Zakarya Ali Saleh Al-Zamani
- Department of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi, India
- Department of Food Technology & Science, Faculty of Agriculture and Veterinary Medicine, Ibb University, Ibb, Yemen
| | - Pankaj Kumar
- Department of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi, India
| | - Upendra Singh
- Department of Agriculture Engineering, SKN College of Agriculture, SKNAU, Jobner, Rajasthan, India
| | - Kamlesh Kumar Meena
- Department of Dairy and Food Microbiology, College of Dairy and Food Technology, MPUAT, Udaipur, India
| | - Durga Shankar Bunkar
- Department of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi, India
| | - Vinod Kumar Paswan
- Department of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi, India
| |
Collapse
|
4
|
Bakshi S, Paswan VK, Yadav SP, Bhinchhar BK, Kharkwal S, Rose H, Kanetkar P, Kumar V, Al-Zamani ZAS, Bunkar DS. A comprehensive review on infant formula: nutritional and functional constituents, recent trends in processing and its impact on infants' gut microbiota. Front Nutr 2023; 10:1194679. [PMID: 37415910 PMCID: PMC10320619 DOI: 10.3389/fnut.2023.1194679] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2023] [Accepted: 05/30/2023] [Indexed: 07/08/2023] Open
Abstract
Human milk is considered the most valuable form of nutrition for infants for their growth, development and function. So far, there are still some cases where feeding human milk is not feasible. As a result, the market for infant formula is widely increasing, and formula feeding become an alternative or substitute for breastfeeding. The nutritional value of the formula can be improved by adding functional bioactive compounds like probiotics, prebiotics, human milk oligosaccharides, vitamins, minerals, taurine, inositol, osteopontin, lactoferrin, gangliosides, carnitine etc. For processing of infant formula, diverse thermal and non-thermal technologies have been employed. Infant formula can be either in powdered form, which requires reconstitution with water or in ready-to-feed liquid form, among which powder form is readily available, shelf-stable and vastly marketed. Infants' gut microbiota is a complex ecosystem and the nutrient composition of infant formula is recognized to have a lasting effect on it. Likewise, the gut microbiota establishment closely parallels with host immune development and growth. Therefore, it must be contemplated as an important factor for consideration while developing formulas. In this review, we have focused on the formulation and manufacturing of safe and nutritious infant formula equivalent to human milk or aligning with the infant's needs and its ultimate impact on infants' gut microbiota.
Collapse
Affiliation(s)
- Shiva Bakshi
- Department of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi, India
| | - Vinod Kumar Paswan
- Department of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi, India
| | - Satya Prakash Yadav
- Department of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi, India
| | - Basant Kumar Bhinchhar
- Department of Livestock Production Management, Sri Karan Narendra Agriculture University, Jobner, India
| | - Sheela Kharkwal
- Department of Agriculture Economics, Sri Karan Narendra Agriculture University, Jobner, India
| | - Hency Rose
- Division of Dairy Technology, ICAR—National Dairy Research Institute, Karnal, India
| | - Prajasattak Kanetkar
- Department of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi, India
| | - Vishal Kumar
- Department of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi, India
| | - Zakarya Ali Saleh Al-Zamani
- Department of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi, India
- Department of Food Technology and Science, Faculty of Agriculture and Veterinary Medicine, Ibb University, Ibb, Yemen
| | - Durga Shankar Bunkar
- Department of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi, India
| |
Collapse
|
5
|
Rose H, Bakshi S, Kanetkar P, Lukose SJ, Felix J, Yadav SP, Gupta PK, Paswan VK. Development and Characterization of Cultured Buttermilk Fortified with Spirulina plantensis and Its Physico-Chemical and Functional Characteristics. Dairy 2023. [DOI: 10.3390/dairy4020019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/30/2023] Open
Abstract
In recent years, there has been an unprecedented increase in the demand for fermented dairy products due to medical recommendations and lifestyle preferences. Cultured buttermilk, as an ancient fermented dairy beverage, is an appropriate product choice in this context. This study presents a novel cultured buttermilk formulated by fortification with high protein microalgae Spirulina platensis, thus making it valuable and attractive because of its antioxidant properties. The fermentation process, nutraceutical properties, and sensory characteristics of developed cultured buttermilk with various concentrations of Spirulina (0.25, 0.5, and 1%) were compared with the control sample (0% Spirulina buttermilk). Different concentrations of Spirulina in buttermilk result in a significant increase in chlorophyll and carotenoid content, boosting its antioxidant properties. The study also evaluated the prebiotic properties of Spirulina, thus, demonstrating its ability to promote a healthy digestive system. It was found that the addition of 0.25% Spirulina was able to ferment the product more quickly and retained the sensory acceptability of the finished product. The protein content, free radical scavenging activity, chlorophyll, carotenoid, and total phenolic content of 0.25% Spirulina-fortified buttermilk was 1.83%, 48.19%, 30.9 mg/g, 8.24 mg/g, and 4.21 mg/g GAE, respectively. Based on the results obtained, it was concluded that cultured buttermilk with a high nutritional value and functional health benefits can be developed by fortification with 0.25% Spirulina as a natural ingredient.
Collapse
|
6
|
Kumar R, Sahu DS, Chandra G, Yadav SP, Kumar R, Ali N, Roy D, Maurya PS. Effect of Astaxanthin and Copper Supplementation on Growth, Immunity, Antioxidant, and Blood Biochemical Status of Growing Murrah Buffalo Heifers. Biol Trace Elem Res 2022; 200:5052-5063. [PMID: 35061144 DOI: 10.1007/s12011-021-03091-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/02/2021] [Accepted: 12/28/2021] [Indexed: 11/02/2022]
Abstract
This study was aimed to explore the effect of astaxanthin (ASTX) and copper (Cu) supplementation on the growth, immunity, antioxidant, and blood biochemical status of growing Murrah buffalo heifers. Twenty-eight Murrah buffalo heifers were selected and randomly divided into 4 groups (n = 7) after blocking by body weight (BW) (129.86 ± 5.37 kg) and age (9.05 ± 1.02 months). The heifers were fed basal total mixed ration diet without supplementation (CON) or with ASTX (0.20 mg/kg BW; AX), Cu (10 mg/kg DM; CU), or ASTX + Cu (0.20 mg/kg BW + 10 mg/kg DM; AX + CU) for 90 days of study period. The result showed that BW and dry matter intake (DMI) were significantly higher (P < 0.05) in AX + CU than that in other groups. The average daily gain (ADG) and feed conversion efficiency (FCE) were statistically higher (P < 0.05) in treatments than the values observed in CON. The feed conversion ratio (FCR) was reported significantly lower (P < 0.05) in the AX + CU group followed by AX, CU, and CON groups. The total leukocytes count (TLC), lymphocytes, and total immunoglobulin (TIG) were statistically higher (P < 0.05) in AX + CU groups than that found in other groups. However, neutrophil % decreased (P < 0.05) in the AX + CU group than its level in other groups. Superoxide dismutase (SOD), catalase (CAT), and total antioxidant (TAA) levels were observed higher (P < 0.05) in treatments supplemented with ASTX, Cu, or both than CON group. Thiobarbituric acid reactive substance (TBARS) concentration was lower (P < 0.05) in treatments than its level found in the CON group. Glucose level was higher (P < 0.05); however, non-esterifies fatty acid (NEFA) was lower (P < 0.05) in AX + CU than that in others groups. The level of cholesterol (CH), HDL cholesterol (HDL-CH), alkaline phosphatase (ALP), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were reported lower (P < 0.05) in the AX + CU group followed by CU, AX, and CON groups. The copper (Cu) level was higher (P < 0.05) in CU and AX + CU than AX and CON groups. The result of the present study indicated that the supplementation of ASTX, Cu alone, or their combination improved the growth, immunity, antioxidant status, and liver function of growing heifers.
Collapse
Affiliation(s)
- Rajesh Kumar
- Department of Animal Husbandry, College of Veterinary and Animal Sciences, Sardar Vallabhbhai Patel University of Agriculture and Technology, Meerut, 250110, UP, India
| | - Deo Saran Sahu
- Department of Animal Husbandry, College of Veterinary and Animal Sciences, Sardar Vallabhbhai Patel University of Agriculture and Technology, Meerut, 250110, UP, India
| | - Gulab Chandra
- Department of Veterinary Physiology and Biochemistry, College of Veterinary and Animal Sciences, Sardar Vallabhbhai Patel University of Agriculture and Technology, Meerut, 250110, UP, India.
| | - Satya Prakash Yadav
- Department of Animal Husbandry, College of Veterinary and Animal Sciences, Sardar Vallabhbhai Patel University of Agriculture and Technology, Meerut, 250110, UP, India
| | - Raj Kumar
- Department of Animal Husbandry, College of Veterinary and Animal Sciences, Sardar Vallabhbhai Patel University of Agriculture and Technology, Meerut, 250110, UP, India
| | - Nazim Ali
- Department of Animal Husbandry, College of Veterinary and Animal Sciences, Sardar Vallabhbhai Patel University of Agriculture and Technology, Meerut, 250110, UP, India
| | - Debashis Roy
- Department of Animal Nutrition, College of Veterinary and Animal Sciences, Sardar Vallabhbhai Patel University of Agriculture and Technology, Meerut, 250110, UP, India
| | - Prem Sagar Maurya
- Department of Veterinary Parasitology, College of Veterinary and Animal Sciences, Sardar Vallabhbhai Patel University of Agriculture and Technology, Meerut, 250110, UP, India
| |
Collapse
|
7
|
Rani P, Verma S, Yadav SP, Rai BK, Naruka MS, Kumar D. Simulation of the Lightweight Blockchain Technique Based on Privacy and Security for Healthcare Data for the Cloud System. International Journal of E-Health and Medical Communications 2022. [DOI: 10.4018/ijehmc.309436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Information about healthcare is derived from healthcare data. Healthcare data sharing helps make healthcare systems more efficient as well as improving healthcare quality. Patients should own and control healthcare information, one of their most valuable assets, instead of letting data be spread out among health care providers differ. This protects data from being shared between healthcare systems and privacy. Public ledger accompanied by a decentralized network of peer's compromises patient has been demonstrated to be able to achieve trusted, auditable computing by blockchain. The use of access control and cryptographic primitives are insufficient in addressing modern cyber threats all privacy and security concerns associated with a cloud-based environment. In this paper, the authors proposed a lightweight blockchain technique based on privacy and security for healthcare data for the cloud system. The cost-effectiveness of our system's smart contracts is evaluated, as well as the procedures used for data processing in order to encrypt and pseudonymize patient data.
Collapse
Affiliation(s)
- Preeti Rani
- SRM Institute of Science and Technology, India
| | - Sonia Verma
- SRM Institute of Science and Technology, India
| | - Satya Prakash Yadav
- Department of Computer Science and Engineering, GL Bajaj Institute of Technology and Management (GLBITM), Affiliated to AKTU, Greater Noida, India
| | | | | | | |
Collapse
|
8
|
Abstract
Introduction Coronavirus disease 2019 (COVID-19) affects children but mostly has mild course. There is meagre published data on the impact of COVID-19 illness in children with Severe Aplastic anemia (SAA). We describe our experience of managing COVID-19 in children with SAA. Method Three children of SAA who developed SARS-CoV-2 infection are included in this study. Results Patient 1 was post Immunosuppressive therapy (IST) for SAA and had an asymptomatic course and uneventful recovery. Patient 2 was several months post IST with no response and had an asymptomatic COVID-19 illness but had delayed viral clearance, however he succumbed to bacterial sepsis soon after. Patient 3 was awaiting IST and while he contracted severe acute respiratory syndrome-Coronavirus-2 (SARS-CoV-2) infection, he had symptomatic COVID-19 illness followed by bacterial and fungal sepsis to which he succumbed. Conclusion: COVID-19 in children with SAA can be mild to fatal course and virus may have delayed clearance. It can lead to delay in therapy of SAA.
Collapse
|
9
|
Yadav SP. Impact of COVID19 on Children with Blood and Cancer Disorders. Pediatric Hematology Oncology Journal 2022. [PMCID: PMC9132720 DOI: 10.1016/j.phoj.2022.05.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/05/2022] Open
|
10
|
Yadav A, Rastogi N, Upasana K, Arora S, Thakkar D, Yadav SP. Milder COVID-19 in children with inborn errors of immunity. Pediatric Hematology Oncology Journal 2022. [PMCID: PMC9076078 DOI: 10.1016/j.phoj.2022.05.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
11
|
Upasana K, Thakkar D, Gautam D, Sachdev MS, Yadav A, Kapoor R, Raghunathan V, Dhaliwal MS, Bhargava K, Nair S, Sharma J, Rastogi N, Yadav SP. Wilms tumor with Mulibrey Nanism: A case report and review of literature. Cancer Rep (Hoboken) 2022; 5:e1512. [PMID: 34309235 PMCID: PMC9124505 DOI: 10.1002/cnr2.1512] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2021] [Revised: 06/21/2021] [Accepted: 07/02/2021] [Indexed: 11/06/2022] Open
Abstract
BACKGROUND Mulibrey-Nanism (Muscle-liver-brain-eye Nanism = dwarfism; MUL) is a rare genetic syndrome. The underlying TRIM37 mutation predisposes these children to develop tumors frequently. In the largest published series of MUL, 8% patients were reported to develop Wilms tumor (WT). The published literature lacks data regarding the best treatment protocol and outcome of this cohort of children with WT and MUL. We report here a 2-year-old boy with WT and MUL and present a review of literature on WT in MUL. CASE Our patient had associated cardiac problems of atrial septal defect, atrial flutter and an episode of sudden cardiac arrest. We managed him successfully with chemotherapy, surgery and multi-speciality care. He is alive and in remission at follow-up of 6 months. CONCLUSION A total of 14 cases (including present case) of WT have been reported in MUL and treatment details were available for six cases. They were managed primarily with surgery, chemotherapy with/without radiotherapy, and all achieved remission. The outcome data is available only for two cases, one has been followed up till 15 years post treatment for WT and other is our patient.
Collapse
Affiliation(s)
- Karthik Upasana
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer InstituteMedanta The Medicity HospitalGurgaonHaryanaIndia
| | - Dhwanee Thakkar
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer InstituteMedanta The Medicity HospitalGurgaonHaryanaIndia
| | - Dheeraj Gautam
- Department of PathologyMedanta The MedicityGurgaonHaryanaIndia
| | | | - Anjali Yadav
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer InstituteMedanta The Medicity HospitalGurgaonHaryanaIndia
| | - Rohit Kapoor
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer InstituteMedanta The Medicity HospitalGurgaonHaryanaIndia
| | - Veena Raghunathan
- Pediatric Intensive Care Unit, Department of PediatricsMedanta The MedicityGurgaonHaryanaIndia
| | - Maninder Singh Dhaliwal
- Pediatric Intensive Care Unit, Department of PediatricsMedanta The MedicityGurgaonHaryanaIndia
| | - Kartikeya Bhargava
- Department of Electrophysiology and Pacing, Heart InstituteMedanta The MedicityGurgaonHaryanaIndia
| | | | | | - Neha Rastogi
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer InstituteMedanta The Medicity HospitalGurgaonHaryanaIndia
| | - Satya Prakash Yadav
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer InstituteMedanta The Medicity HospitalGurgaonHaryanaIndia
| |
Collapse
|
12
|
Raj R, Uppuluri R, Parambil B, Dhariwal N, Totadri S, Mathew LG, Radhakrishnan V, Charan A, Yadav SP, Mahajan A, Mudaliar S, Sharma R, Manglani M, Kharya G, Verma N, Arora R, Ghara N, Ks R, Radhakrishnan N, Iyer N, Mehta P, Singh A, Patel S, John J, Bhat S, Badiger S, Siddaiahgari S, Kakkar S, Scott J, Jayaraman D, Srinivasan A, Krishnan Y, Sonamani N, Misra R, Bafna V, Seth R, Kutty PK, Kanakia S, Rao V, Prakash A, Bharadwaj V, Chinnasamy G. Outcomes of COVID-19 in children with cancer – Report from the Indian Pediatric Oncology Group (InPOG) COVID-19 registry in India. Pediatric Hematology Oncology Journal 2022. [PMCID: PMC8920536 DOI: 10.1016/j.phoj.2022.03.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Introduction The clinical outcomes of COVID-19 infection in children with cancer have been variable worldwide. Therefore, we aimed to collect data from all regions in India through a national collaborative study and identify factors that cause mortality directly related to COVID-19 infection. Methods Data was collected prospectively on children across India on cancer therapy and diagnosed with COVID-19 infections from 47 centers from April 2020 to October 2021. Information was recorded on the demographics, the number of children that required intervention, and the outcome of the infection. In addition, we analyzed the impact of the delta variant in 2021. Results A total of 659 children were studied, of whom 64% were male and 36% were female. The data from the eastern region was sparse, and this was a collection bias. COVID-19 infection was predominantly seen in children less than five years. The delta variant had a higher impact in the southern region, and this was statistically significant. Of the 659 children, 30 children died (4.5%), however only 7 of the deaths were directly attributed to COVID-19 infection (1%). Conclusion The study reports the largest nationally representative cohort of children with cancer and COVID-19 to date in India. We identified demographic and clinical factors associated with increased all-cause mortality in patients with cancer. Complete characterization of the cohort has provided further insights into the effects of COVID-19 on cancer outcomes. The low mortality allows us to recommend that specific cancer treatments be continued without delays in therapy.
Collapse
|
13
|
Thakkar D, Upasana K, Arora S, Chadha R, Udayakumar D, Jha B, Yadav A, Rastogi N, Goel S, Saxena R, Yadav SP. Treatment of pediatric acute lymphoblastic leukemia in India on BFM 95 protocol backbone with relevant modifications and minimal residual disease application - Doable and effective. Pediatric Hematology Oncology Journal 2022. [DOI: 10.1016/j.phoj.2022.10.189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
14
|
Arora S, Thakkar D, Rastogi N, Modi J, Sharma J, Upasana K, Yadav A, Yadav SP. Posterior reversible encephalopathy syndrome (PRES) in pediatric hematology, oncology and post hematopoietic stem cell transplant: A single centre experience. Pediatric Hematology Oncology Journal 2022. [DOI: 10.1016/j.phoj.2022.10.217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
15
|
Rastogi N, Misra R, Yadav A, Arora S, Kartik U, Thakkar D, Yadav SP. Hematopoetic stem cell transplantation for inborn errors of metabolism - An experience from a tertiary care centre in India. Pediatric Hematology Oncology Journal 2022. [DOI: 10.1016/j.phoj.2022.10.074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
16
|
Rastogi N, Jaggi S, Nair S, Kartik U, Arora S, Yadav A, Thakkar D, Yadav SP. Psychological impact of art therapy on children undergoing leukaemia treatment. Pediatric Hematology Oncology Journal 2022. [DOI: 10.1016/j.phoj.2022.10.083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
17
|
Thakkar D, Yadav A, Mahendru S, Brajesh V, Singh S, Singh A, Upasana K, Arora S, Rastogi N, Khazanchi RK, Yadav SP. Plastic surgery support in necrotising skin/soft tissue infections in paediatric haematology oncology and BMT. Pediatric Hematology Oncology Journal 2021. [DOI: 10.1016/j.phoj.2022.03.162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
18
|
Arora S, Rastogi N, Upasana K, Yadav A, Thakkar D, Yadav SP. Allogeneic hematopoietic stem cell transplantation for paediatric myelodysplastic syndrome: A single centre experience. Pediatric Hematology Oncology Journal 2021. [DOI: 10.1016/j.phoj.2022.03.115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
19
|
Upasana K, Singh D, Raghunathan V, Arora S, Thakkar D, Yadav A, Dhaliwal MS, Rastogi N, Chadha R, Yadav SP. Improving diagnosis of hematophagocytic lymphohystiocytosis in children with severe dengue. Pediatric Hematology Oncology Journal 2021. [DOI: 10.1016/j.phoj.2022.03.085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
20
|
Arora S, Thakkar D, Upasana K, Yadav A, Rastogi N, Pabbi S, Aggarwal G, Tiwari A, Gupta S, Yadav SP. Dexamethasnoe mobilised granulocyte transfusions for severe infection in pediatric oncology patients with neutropenia. Pediatric Hematology Oncology Journal 2021. [DOI: 10.1016/j.phoj.2022.03.154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
21
|
Arora S, Thakkar D, Upasana K, Yadav A, Rastogi N, Yadav SP. Bacillus cereus infection in pediatric oncology patients: A case report and review of literature. IDCases 2021; 26:e01302. [PMID: 34745884 PMCID: PMC8554482 DOI: 10.1016/j.idcr.2021.e01302] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2021] [Revised: 09/26/2021] [Accepted: 10/04/2021] [Indexed: 11/29/2022] Open
Abstract
Introduction Bacillus Cereus infection can be life-threatening in immunocompromised patients. We report here a case of Bacillus Cereus septicemia in a child with relapsed acute lymphoblastic leukemia (ALL) and present review of literature. Methods We collected clinical, laboratory and outcome data of our patient with relapsed ALL and Bacillus Cereus infection. We reviewed literature for Bacillus Cereus infection in pediatric oncology patients by searching MED-LINE/PubMed/Google/Google Scholar/Cochrane and summarized the data obtained. Various risk factors like presence of gastrointestinal or central nervous system (CNS) symptoms, neutropenia, central venous catheter in-situ, corticosteroids use, intrathecal chemotherapy and outcomes were analyzed using Fisher Exact Chi Square test. Results A 15-years-old boy with relapsed ALL on induction chemotherapy presented with giddiness and difficulty in breathing. He had an episode of hematemesis followed by fainting at home. He had refractory shock which did not respond to fluid boluses, inotropes and hydrocortisone. He had severe metabolic acidosis with high lactate and ammonia and died within 36-hours of onset of symptoms. His blood culture was positive for Bacillus Cereus. We came across 36 published cases of Bacillus Cereus in children with cancer including present case. Of these, 28 had acute leukemia and rest 8 had other cancers. CNS symptoms were present in 13 patients. Overall mortality was 25%. Patients with multisystem involvement had significantly higher mortality compared to those having localized disease (p-value 0.033). Conclusion In pediatric oncology patients on chemotherapy, cultures positive for Bacillus Cereus should be considered significant. Mortality is higher in those with multisystem involvement.
Collapse
Affiliation(s)
| | | | | | | | | | - Satya Prakash Yadav
- Correspondence to: Pediatric Hematology Oncology & BMT Unit, Cancer Institute, Medanta -The Medicity, Gurgaon, Haryana 122001, India.
| |
Collapse
|
22
|
Yadav A, Thakkar D, Wadhwa T, Sarma S, Upasana K, Rastogi N, Yadav SP. COVID-19 in children with blood and cancer disorders: An experience from India. Pediatric Hematology Oncology Journal 2021. [PMCID: PMC8517390 DOI: 10.1016/j.phoj.2021.10.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
|
23
|
Thakkar D, Tiwari AK, Pabbi S, Kapoor R, Aggarwal G, Rastogi N, Yadav SP. Peripheral blood stem cell mobilization with pegylated granulocyte colony stimulating factor in children. Cancer Rep (Hoboken) 2021; 4:e1408. [PMID: 34245131 PMCID: PMC8714533 DOI: 10.1002/cnr2.1408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2020] [Revised: 03/20/2021] [Accepted: 03/30/2021] [Indexed: 11/09/2022] Open
Abstract
BACKGROUND AND AIM We report here our experience of using pegylated granulocyte colony stimulating factor (peg-GCSF) for peripheral blood stem cell (PBSC) mobilization in children. METHODS AND RESULTS A total of nine children suffering from high-risk/relapsed solid tumors were mobilized with chemotherapy and peg-GCSF (100 microgram/kg single dose). Mean age was 7.7 years (range 2-15 years).The mean time from peg-GCSF administration to PBSC harvest was 9.7 days. Adequate stem cells (median dose 26.9 million/kg) could be harvested in all children by a single apheresis procedure. No major adverse events observed. CONCLUSION It is feasible and safe to mobilize PBSC with peg-GCSF in children with cancer.
Collapse
Affiliation(s)
- Dhwanee Thakkar
- Department of Pediatric Hematology Oncology and BMT, Medanta The Medicity, Gurgaon, India
| | - Aseem K Tiwari
- Department of Transfusion Medicine, Medanta The Medicity, Gurgaon, India
| | - Swati Pabbi
- Department of Transfusion Medicine, Medanta The Medicity, Gurgaon, India
| | - Rohit Kapoor
- Department of Pediatric Hematology Oncology and BMT, Medanta The Medicity, Gurgaon, India
| | - Geet Aggarwal
- Department of Transfusion Medicine, Medanta The Medicity, Gurgaon, India
| | - Neha Rastogi
- Department of Pediatric Hematology Oncology and BMT, Medanta The Medicity, Gurgaon, India
| | - Satya Prakash Yadav
- Department of Pediatric Hematology Oncology and BMT, Medanta The Medicity, Gurgaon, India
| |
Collapse
|
24
|
Yadav A, Rastogi N, Upasana K, Arora S, Thakkar D, Yadav SP. Dengue virus transmission from donor to recipient during haploidentical stem cell transplantation. IDCases 2021; 25:e01220. [PMID: 34295644 PMCID: PMC8282947 DOI: 10.1016/j.idcr.2021.e01220] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2021] [Revised: 07/06/2021] [Accepted: 07/06/2021] [Indexed: 11/24/2022] Open
Abstract
Dengue fever is endemic in tropical and subtropical countries. Dengue virus transmission through hematopoietic stem cells is very rare and just two such cases have been reported previously. We report here only third case of dengue virus transmission in a 2-year-old child with thalassemia major who underwent hematopoietic stem cell transplant (HSCT) from a haploidentical related donor. One week after HSCT, the recipient developed fever, pancytopenia and signs of capillary leak. On day 10, his dengue NS1 antigen test was positive which confirmed diagnosis of dengue fever. Donor also had fever few days prior to stem cell donation which was later diagnosed to be due to dengue fever. Child had a severe clinical course of dengue leading to primary graft failure. However, he had autologous recovery of his own bone marrow and is alive and well on day+200 post HSCT. Our report highlights the transmission of dengue virus from donor to recipient through hematopoietic stem cell graft although rare but possible. We suggest that in tropical and subtropical countries where dengue is endemic, hematopoietic stem cell donors should be screened for it.
Collapse
Affiliation(s)
- Anjali Yadav
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer Institute, Medanta The Medicity Hospital, Gurgaon, Haryana, 122001, India
| | - Neha Rastogi
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer Institute, Medanta The Medicity Hospital, Gurgaon, Haryana, 122001, India
| | - K Upasana
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer Institute, Medanta The Medicity Hospital, Gurgaon, Haryana, 122001, India
| | - Sunisha Arora
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer Institute, Medanta The Medicity Hospital, Gurgaon, Haryana, 122001, India
| | - Dhwanee Thakkar
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer Institute, Medanta The Medicity Hospital, Gurgaon, Haryana, 122001, India
| | - Satya Prakash Yadav
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer Institute, Medanta The Medicity Hospital, Gurgaon, Haryana, 122001, India
| |
Collapse
|
25
|
Sharma S, Rathod S, Prakash Yadav S, Chakraborty A, Shukla AK, Aetukuri N, Patil S. Electrochemical Evaluation of Diketopyrrolopyrrole Derivatives for Nonaqueous Redox Flow Batteries. Chemistry 2021; 27:12172-12180. [PMID: 34041796 DOI: 10.1002/chem.202101516] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2021] [Indexed: 11/06/2022]
Abstract
Redox flow batteries (RFBs) employing nonaqueous electrolytes could potentially operate at much higher cell voltages, and therefore afford higher energy and power densities, than RFBs employing aqueous electrolytes. The development of such high-voltage nonaqueous RFBs requires anolytes that are electrochemically stable, especially in the presence of traces of oxygen and/or moisture. The inherent atmospheric reactivity of anolytes mandates judicious molecular design with high electron affinity and electrochemical stability. In this study, diketopyrrolopyrrole (DPP)-based TDPP-Hex-CN4 is proposed as a stable redox-active molecule for anolytes in nonaqueous organic RFBs. We demonstrate organic RFBs using TDPP-Hex-CN4 as anolyte with unisol blue (UB) 1,4-bis(isopropylamino)anthraquinone and 1,4-di-tert-butyl-2,5-bis(2-methoxyethoxy)benzene (DBBB) as catholytes. Cyclic voltammetry measurements with scans repeated over 200 cycles were performed to establish the electrochemical stability of the redox pairs. Symmetric flow-cell studies show that TDPP-Hex-CN4 exhibits stable capacity up to 700 cycles. Redox flow cells employing TDPP-Hex-CN4 /UB and TDPP-Hex-CN4 /DBBB as redox pairs demonstrate that DPP derivatives are propitious materials for anolytes in all organic nonaqueous RFBs.
Collapse
Affiliation(s)
- Shikha Sharma
- Solid State and Structural Chemistry Unit, Indian Institute of Science, Bangalore, 560012, India
| | - Suman Rathod
- Solid State and Structural Chemistry Unit, Indian Institute of Science, Bangalore, 560012, India
| | - Satya Prakash Yadav
- Solid State and Structural Chemistry Unit, Indian Institute of Science, Bangalore, 560012, India
| | - Arunavo Chakraborty
- Solid State and Structural Chemistry Unit, Indian Institute of Science, Bangalore, 560012, India
| | - Ashok K Shukla
- Solid State and Structural Chemistry Unit, Indian Institute of Science, Bangalore, 560012, India
| | - Nagaphani Aetukuri
- Solid State and Structural Chemistry Unit, Indian Institute of Science, Bangalore, 560012, India
| | - Satish Patil
- Solid State and Structural Chemistry Unit, Indian Institute of Science, Bangalore, 560012, India
| |
Collapse
|
26
|
Yadav SP. Magnitude and Trends of Childhood Cancer in India. Indian Pediatr 2021; 58:415-416. [PMID: 33980726] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Affiliation(s)
- Satya Prakash Yadav
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer Institute, Medanta The Medicity Hospital, Gurgaon, Haryana, 122001.
| |
Collapse
|
27
|
Affiliation(s)
- Satya Prakash Yadav
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer Institute, Medanta The Medicity Hospital, Gurgaon, Haryana, India
| | - Teena Wadhwa
- Department of Microbiology, Medanta The Medicity, Gurgaon, Haryana, India
| | - Dhwanee Thakkar
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer Institute, Medanta The Medicity Hospital, Gurgaon, Haryana, India
| | - Rohit Kapoor
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer Institute, Medanta The Medicity Hospital, Gurgaon, Haryana, India
| | - Neha Rastogi
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer Institute, Medanta The Medicity Hospital, Gurgaon, Haryana, India
| | - Smita Sarma
- Department of Microbiology, Medanta The Medicity, Gurgaon, Haryana, India
| |
Collapse
|
28
|
Affiliation(s)
- Neha Rastogi
- Paediatric Hematology Oncology and Bone Marrow Transplantation, Medanta - The Medicity, Gurgaon, India
| | - Goutomi Chatterjee
- Paediatric Hematology Oncology and Bone Marrow Transplantation, Medanta - The Medicity, Gurgaon, India
| | - Ritu Chadda
- Department of Hematopathology, Medanta - The Medicity, Gurgaon, India
| | - Satya Prakash Yadav
- Paediatric Hematology Oncology and Bone Marrow Transplantation, Medanta - The Medicity, Gurgaon, India
| |
Collapse
|
29
|
Jhala Y, Gopal R, Mathur V, Ghosh P, Negi HS, Narain S, Yadav SP, Malik A, Garawad R, Qureshi Q. Recovery of tigers in India: Critical introspection and potential lessons. People and Nature 2021. [DOI: 10.1002/pan3.10177] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023] Open
Affiliation(s)
| | | | - Vaibhav Mathur
- National Tiger Conservation Authority Ministry of Environment Forest and Climate Change Government of India New Delhi India
| | - Prodipto Ghosh
- The Energy and Resources Institute India Habitat Center New Delhi India
| | | | - Sunita Narain
- Center for Science and Environment India Habitat Center New Delhi India
| | - Satya Prakash Yadav
- National Tiger Conservation Authority Ministry of Environment Forest and Climate Change Government of India New Delhi India
| | - Amit Malik
- National Tiger Conservation Authority Ministry of Environment Forest and Climate Change Government of India New Delhi India
| | - Rajendra Garawad
- National Tiger Conservation Authority Ministry of Environment Forest and Climate Change Government of India New Delhi India
| | | |
Collapse
|
30
|
Kohli S, Chadha R, Rastogi N, Yadav SP. High serum ferritin alone as a predictor of mortality and hemophagocytic lymphohistiocytosis. eJHaem 2021; 2:136-138. [PMID: 35846094 PMCID: PMC9175966 DOI: 10.1002/jha2.153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 10/29/2020] [Revised: 11/26/2020] [Accepted: 12/01/2020] [Indexed: 11/05/2022]
Affiliation(s)
- Shruti Kohli
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit Medanta ‐ The Medicity Hospital Cancer Institute Gurgaon India
| | - Ritu Chadha
- Department of Hematopathology Medanta ‐ The Medicity Hospital Gurgaon India
| | - Neha Rastogi
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit Medanta ‐ The Medicity Hospital Cancer Institute Gurgaon India
| | - Satya Prakash Yadav
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit Medanta ‐ The Medicity Hospital Cancer Institute Gurgaon India
| |
Collapse
|
31
|
Wang TY, Yang ZZ, Chen JH, Liu Y, Kamar S, Chen QY, Yuan T, Yang XH, Zhang J, Wang C, Yadav SP, Shrestha S, Yang YH, Li DQ. [Clinical study of percutaneous vertebroplasty combined with (125)I seeds implantation in the treatment of patients with thoracic metastatic tumor complicated with posterior vertebral defect]. Zhonghua Zhong Liu Za Zhi 2021; 42:1056-1062. [PMID: 33342165 DOI: 10.3760/cma.j.cn112152-20200228-00145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To analyze the safety and efficacy of percutaneous vertebroplasty combined with interstitial implantation (125)I of seeds (PVPI) in the treatment of thoracic vertebroplasty with posterior vertebra defect. Methods: A retrospective analysis of the clinical data of 64 patients with thoracic spine metastases admitted to Yunnan Cancer Hospital from November 2017 to May 2019 was conducted, including 32 patients with posterior vertebra defect (experimental group) and 32 cases without (control group). Forty-two vertebral bodies of 32 patients in the experimental group were treated with improved PVPI surgery, which performed with the secondary sealing method and inclined puncture needle injection bone cement rotary filling technology, to reduce leakage. The 54 vertebral bodies of 32 patients in control group underwent PVPI. The two groups of patients were followed up on the second day, one month, three months and six months after the operation, and the short-term efficacy, long-term efficacy and safety indicators of the two groups were compared. Results: All 64 patients successfully completed the surgical treatment. The visual analogue scores and Karnofsky scores of the experimental group and the control group were improved to varying degrees on the second day, 1 month, 3 months and 6 months after the operation. There was no statistically significant difference between the two groups (P>0.05). The amount of bone cement in the experimental group and control group was (2.36±0.20) ml and (2.39±0.17) ml, and the difference was not statistically significant (P=0.482). The amount of (125)I seed implantation was (30.63±0.91) and (32.56±0.68), respectively, the difference was not statistically significant (P=0.925). The partial response rates of the study group and the control group were 81.3% and 87.5%, the stable disease rates were 12.5% and 9.4%, the differences were not statistically significant (P>0.05). The median overall survival (mOS) of the study group was 13 months, and the median progression-free survival (mPFS) was 8 months. The mOS of the control group was 14 months, and the mPFS was 8 months. The differences were not statistically significant (P>0.05). In the experimental group, 6 (14.3%) vertebral bodies had cement leakage, of which 2 (4.8%) were cement leakage at posterior vertebra, 4 (9.5%) were paravertebral cement leakage. Seven (13.0%) paravertebral cement leakage occurred in the control group. There was no significant difference in bone cement leakage between the two groups (P=0.097). Bone cement leakage in both groups did not cause serious complications such as spinal cord injury and paraplegia. Conclusion: The application of PVPI in the treatment of thoracic metastatic tumor patients with posterior vertebra defect can acquire better clinical efficacy and safety through conduction of the improved intraoperative technology and paying more attention to the control of bone cement distribution and other issues.
Collapse
Affiliation(s)
- T Y Wang
- Department of Orthopedics, the Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China
| | - Z Z Yang
- Department of Orthopedics, the Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China
| | - J H Chen
- Department of Orthopedics, the Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China
| | - Y Liu
- Department of Orthopedics, the Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China
| | - S Kamar
- Department of Orthopedics, the Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China
| | - Q Y Chen
- Department of Orthopedics, the Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China
| | - T Yuan
- Department of Orthopedics, the Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China
| | - X H Yang
- Department of Bone Tumor, Changzheng Hospital, Navy Medical University, Shanghai 200003, China
| | - J Zhang
- Department of Orthopedics, the Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China
| | - C Wang
- Department of Orthopedics, the Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China
| | - S P Yadav
- Department of Orthopedics, the Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China
| | - S Shrestha
- Department of Orthopedics, the Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China
| | - Y H Yang
- Department of Orthopedics, the Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China
| | - D Q Li
- Department of Orthopedics, the Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China
| |
Collapse
|
32
|
Raj R, Aboobacker FN, Yadav SP, Uppuluri R, Bhat S, Choudhry D, Dua V, Kharya G, Rastogi N, Sachdev M, Khandelwal V, Swaminathan V, Bakane A, Ramakrishnan B, George B. Multicenter Outcome of Hematopoietic Stem Cell Transplantation for Primary Immune Deficiency Disorders in India. Front Immunol 2021; 11:606930. [PMID: 33488609 PMCID: PMC7819851 DOI: 10.3389/fimmu.2020.606930] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2020] [Accepted: 11/03/2020] [Indexed: 11/13/2022] Open
Abstract
Background Hematopoietic stem cell transplantation (HSCT) is the curative option for many primary immune deficiency disorders (PID). In the last 5 years, increased awareness, availability of diagnostics based on flow cytometry, genetic testing, improved supportive care, use of reduced toxicity conditioning, and success of haploidentical donor HSCT have improved access to HSCT for children with PID in India. We present results on children with PID who underwent HSCT across India and the factors that influenced outcome. Patients and Methods We collected retrospective data on the outcome of HSCT for PID from seven centers. We analyzed the impact of the type of PID, conditioning regimen, time period of HSCT- before or after January 2016, graft versus host disease prophylaxis, cause of mortality and overall survival. Results A total of 228 children underwent HSCT for PID at a median age of 12 months (range, 1 to 220 months) with a median follow up of 14.4 months. Infants accounted for 51.3% of the cohort and the male female ratio was 3:1. SCID (25%) and HLH (25%) were the more frequent diagnoses. Matched family donor was available in 36.4% and 44.3% children had a haploidentical HSCT. Reduced and myeloablative conditioning regimens were used with 64% children receiving a treosulfan based conditioning regimen. Peripheral blood stem cells were the predominant graft source at 69.3%. The survival in infants (60.2%) was inferior to children aged over 1 year (75.7% p value = 0.01). Children with Wiskott Aldrich syndrome (74.3%) and chronic granulomatous disease (82.6%) had the best outcomes. The survival was superior in children receiving HSCT from a matched sibling (78%) versus an alternate donor HSCT (61% p value = 0.04). In the cohort transplanted after January 2016 survival improved from 26.8% to 77.5% (p value = 0.00). Infection remains the main cause of mortality at in over 50% children. The 5-year overall survival rate was 68%. Conclusion Survival of children with PID undergoing HSCT in India has improved dramatically in last 5 years. Alternate donor HSCT is now feasible and has made a therapeutic option accessible to all children with PID.
Collapse
Affiliation(s)
- Revathi Raj
- Department of Pediatric Hematology and Oncology, Apollo Cancer Institutes, Chennai, India
| | | | | | - Ramya Uppuluri
- Department of Pediatric Hematology and Oncology, Apollo Cancer Institutes, Chennai, India
| | - Sunil Bhat
- Department of Pediatric Hematology and Oncology, Narayana Health City, Bangalore, India
| | - Dharma Choudhry
- Department of Pediatric Hematology and Oncology, BLK Super Specialty Hospital, New Delhi, India
| | - Vikas Dua
- Department of Pediatric Hematology and Oncology, Fortis Memorial Research Institute, Gurugram, India
| | - Gaurav Kharya
- Department of Pediatric Hematology and Oncology, Indraprastha Apollo Hospital, New Delhi, India
| | - Neha Rastogi
- Pediatric Hemato-Oncology & BMT Unit, Medanta The Medicity, Gurgaon, India
| | - Mansi Sachdev
- Department of Pediatric Hematology and Oncology, Fortis Memorial Research Institute, Gurugram, India
| | - Vipin Khandelwal
- Department of Pediatric Hematology and Oncology, BLK Super Specialty Hospital, New Delhi, India
| | | | - Atish Bakane
- Department of Pediatric Hematology and Oncology, Indraprastha Apollo Hospital, New Delhi, India
| | | | - Biju George
- Department of Hematology, Christian Medical College, Vellore, India
| |
Collapse
|
33
|
Singh D, Raghunathan V, Dhaliwal M, Rastogi N, Chadha R, Yadav SP. Soluble Interleukin-2 Receptor Level as a Marker of Hemophagocytic Lymphohistiocytosis in Children With Severe Dengue. Front Pediatr 2021; 9:721857. [PMID: 34778128 PMCID: PMC8578167 DOI: 10.3389/fped.2021.721857] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/07/2021] [Accepted: 09/20/2021] [Indexed: 01/02/2023] Open
Abstract
Dengue induced-hemophagocytic lymphohistiocytosis (HLH) is increasingly recognized as an important cause of secondary HLH. Early identification of dengue HLH and directed therapy for HLH may help to alter the outcomes in critically ill patients. Soluble interleukin-2 receptor (IL2R) is a useful inflammatory marker and is seen to correlate with HLH disease activity. There is scarcity of data on IL2R in pediatric dengue patients with HLH. All patients (age < 18 years) with severe dengue confirmed by positive dengue IgM ELISA admitted to PICU were retrospectively enrolled. Patientswere screened for presence of HLH according to HLH 2004 criteria. Hemogram, ferritin, fibrinogen, liver, and renal function tests were noted. Patients who met four or more HLH criteria were treated with steroids and IL2R levels were sent to confirm the diagnosis of HLH. Out of 15 patients, nine patients met the criteria of HLH. IL2R levels were high in all HLH patients (mean 51,711, range 18,000-98,715 pg/mL). Mean ferritin levels were high in the HLH group as compared to non-HLH group (mean ferritin 34,593 vs. 3,206 ng/mL; p-value 0.004). Liver dysfunction was notably higher in the HLH group compared to non-HLH group (mean alanine aminotransferase 6,621 U/L vs. 165.6 U/L; p-value 0.04, mean aspartate aminotransferase 2,145 U/L vs. 104.2 U/L; 0.04, bilirubin level 4.2 mg/dL vs. 0.7 mg/dL; p-value 0.03). Four patients in the HLH group had acute kidney injury (AKI) and two required renal replacement therapy in the form of sustained low efficiency dialysis (SLED). Requirement for invasive ventilation was exclusively seen in HLH group and three patients developed ARDS. Two patients each in HLH and non-HLH group had shock requiring vasoactive therapy in addition to fluids. Mean days of ICU and hospital stay were higher in HLH group vs. non-HLH group but not statistically significant (6.4 vs. 4.4; p-value 0.32 and 8.44 vs. 5.6; p-value 0.18 days, respectively). All children in HLH group received steroids as per HLH protocol. In the HLH group, seven survived while two died. In the non-HLH group, all five patients survived. We concluded that IL2R levels are high in dengue HLH and useful for definitive diagnosis. Early recognition of this condition in severe dengue and prompt steroid therapy improves chances of better outcome.
Collapse
Affiliation(s)
| | | | | | | | - Ritu Chadha
- Medanta the Medicity Hospital, Gurgaon, India
| | | |
Collapse
|
34
|
Yadav SP, Thakkar D. Asymptomatic reactivation of SARS-CoV-2 in a child with neuroblastoma characterised by whole genome sequencing. IDCases 2020; 23:e01018. [PMID: 33288996 PMCID: PMC7711173 DOI: 10.1016/j.idcr.2020.e01018] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2020] [Indexed: 12/14/2022] Open
Affiliation(s)
- Satya Prakash Yadav
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer Institute, Medanta The Medicity, Gurgaon, Haryana, India
| | - Dhwanee Thakkar
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer Institute, Medanta The Medicity, Gurgaon, Haryana, India
| |
Collapse
|
35
|
Sharma A, Rastogi N, Kapoor R, Chatterjee G, Nivargi S, Kohli S, Misra R, Yadav SP. Outcomes of pediatric autologous haematopoietic stem cell transplant: A ten years experience. Pediatric Hematology Oncology Journal 2020. [DOI: 10.1016/j.phoj.2021.04.150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
36
|
Chatterjee G, Thakkar D, Kapoor R, Rastogi N, Yadav SP. Outcome of relapse post allogeneic stem cell transplantation for childhood leukemia. Pediatric Hematology Oncology Journal 2020. [DOI: 10.1016/j.phoj.2021.04.153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
37
|
Jategaonkar PA, Yadav SP, Dhaigude PR. A simple method of T-tube preparation for easy accommodation into a non-dilated biliary system. Ann R Coll Surg Engl 2020; 103:74-75. [PMID: 32441542 DOI: 10.1308/rcsann.2020.0111] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023] Open
Affiliation(s)
- P A Jategaonkar
- Mahatma Gandhi Institute of Medical Sciences, Sevagram, India
| | - S P Yadav
- Grant Medical College and Sir J.J. Group of Hospitals, Mumbai, India
| | - P R Dhaigude
- Mahatma Gandhi Institute of Medical Sciences, Sevagram, India
| |
Collapse
|
38
|
Yadav SP, Kale HA, Roy DD, Nakshiwala VB. Discal cyst: A rare cause of low backache. J Postgrad Med 2020; 66:114-115. [PMID: 32270782 PMCID: PMC7239394 DOI: 10.4103/jpgm.jpgm_549_19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Affiliation(s)
- S P Yadav
- Department of Radiology and Imaging, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Four Bungalows, Andheri West, Maharashtra, India
| | - H A Kale
- Department of Radiology and Imaging, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Four Bungalows, Andheri West, Maharashtra, India
| | - D D Roy
- Department of Radiology and Imaging, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Four Bungalows, Andheri West, Maharashtra, India
| | - V B Nakshiwala
- Department of Radiology and Imaging, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Four Bungalows, Andheri West, Maharashtra, India
| |
Collapse
|
39
|
Yadav SP, Sharma A, Kapoor R, Chatterjee G, Thakkar D, Rastogi N. Upfront Haploidentical Stem Cell Transplant with Post Transplant Cyclophosphamide in Children with Severe Aplastic Anemia. Biol Blood Marrow Transplant 2020. [DOI: 10.1016/j.bbmt.2019.12.208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
40
|
Yadav SP, Sharma A, Kapoor R, Chatterjee G, Thakkar D, Rastogi N. Thiotepa Based Conditioning for Haploidentical Stem Cell Transplantation with Post Transplant Cyclophosphamide for Pediatric Acute Leukemia Is Highly Effective. Biol Blood Marrow Transplant 2020. [DOI: 10.1016/j.bbmt.2019.12.719] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
41
|
Yadav SP, Sharma A, Kapoor R, Chatterjee G, Rastogi N. Haploidentical Stem Cell Transplant with Post-Transplant Cyclophosphamide with Busulfan, Fludarabine and Thiotepa Conditioning for Children with Thalassemia Major. Biol Blood Marrow Transplant 2020. [DOI: 10.1016/j.bbmt.2019.12.535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
42
|
Yadav SP, Thakkar D, Rastogi N. Successful Umbilical Cord Blood Stem Cell Transplantation for Pelizaeus Marzbacher Leukodystrophy. Biol Blood Marrow Transplant 2020. [DOI: 10.1016/j.bbmt.2019.12.536] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
43
|
Rastogi N, Yadav SP. Successful treatment of cytomegalovirus encephalitis post TCR-alpha-beta/CD19 depleted haploidentical stem cell transplant by unmanipulated donor lymphocyte infusions. Pediatr Hematol Oncol 2019; 36:520-522. [PMID: 31578121 DOI: 10.1080/08880018.2019.1663326] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- Neha Rastogi
- Pediatric Hematology, Oncology & Bone Marrow Transplantation Unit, Department of Pediatrics, Fortis Memorial Research Institute, Gurgaon, Haryana, India
| | - Satya Prakash Yadav
- Pediatric Hematology, Oncology & Bone Marrow Transplantation Unit, Cancer Institute, Medanta The Medicity, Gurgaon, Haryana, India
| |
Collapse
|
44
|
Chatterjee G, Yadav SP. Portal vein thrombosis in a child with essential thrombocythemia seven years after diagnosis. Pediatr Hematol Oncol 2019; 36:510-513. [PMID: 31718383 DOI: 10.1080/08880018.2019.1665153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Portal vein thrombosis in children with essential thrombocythemia (ET) is a rarity. Here, we describe the long-term follow up of our previously reported case that since has developed portal vein thrombosis (PVT) 7-years after diagnosis. Our patient had presented with PVT with normal platelet counts and massive asymptomatic splenomegaly. Ultrasound and Computerized tomography confirmed presence of PVT. Our case highlights the importance of long-term follow up of children with ET for thrombosis, especially PVT, as it can happen without symptoms and normal platelet counts.
Collapse
Affiliation(s)
- Goutomi Chatterjee
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer Institute, Medanta The Medicity, Gurgaon, Haryana, India
| | - Satya Prakash Yadav
- Pediatric Hematology Oncology and Bone Marrow Transplant Unit, Cancer Institute, Medanta The Medicity, Gurgaon, Haryana, India
| |
Collapse
|
45
|
Yadav SP, Abraham A, Nadig R, Vasudevan A. Burning Feet, Dilated Heart and Failed Kidneys. Indian J Nephrol 2019; 29:357-359. [PMID: 31571744 PMCID: PMC6755931 DOI: 10.4103/ijn.ijn_35_18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
Fabry's disease, X-linked lysosomal storage disease, results from deficient activity of alpha galactosidaseA (α-GalA). Renal manifestation usually begins at third decade of life. We report a 16 year male with initial presentation with end stage renal disease (ESRD) and the diagnosis confirmed by presence of myeloid bodies on electron microscopy of kidney biopsy and low serum α-GalA level.
Collapse
Affiliation(s)
- S P Yadav
- Department of Pediatric Nephrology, St. John's Medical College Hospital, Bengaluru, Karnataka, India
| | - A Abraham
- Renopath Centre for Renal and Urological Pathology Pvt., Ltd., Chennai, Tamil Nadu, India
| | - R Nadig
- Department of Neurology, St. John's Medical College Hospital, Bengaluru, Karnataka, India
| | - A Vasudevan
- Department of Pediatric Nephrology, St. John's Medical College Hospital, Bengaluru, Karnataka, India
| |
Collapse
|
46
|
Sharma A, George B, Subhash C, Bhurani D, Choudhary D, Easow J, John J, Kumar L, Sidharthan N, Malhotra P, Ahmed R, Raj R, Bhargava R, Yadav SP, Damodar S, Nityanand S, Bhat S, Saikia T, Seth T, Nair V, Mathews V. Summary of the Highlights of 2019 ASTCT Meeting by iNDUS BMT Group at Chennai, India. Indian J Hematol Blood Transfus 2019; 35:409-415. [PMID: 31388249 PMCID: PMC6646494 DOI: 10.1007/s12288-019-01152-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2019] [Accepted: 06/18/2019] [Indexed: 10/26/2022] Open
Abstract
This article summarises the main highlights of the abstracts presented at the annual meeting of American Society of Transplantation and Cellular Therapy (ASTCT). The highlights of ASTCT meeting were organised by iNDUS BMT group in Chennai, India. The purpose of the highlight meeting was to educate the students about the latest research in the field of hematopoietic stem cell transplantation and its applicability for the developing country perspective.
Collapse
Affiliation(s)
| | | | | | | | | | - Jose Easow
- Apollo Specialty Hospital, Chennai, India
| | | | | | | | - Pankaj Malhotra
- Department of Internal Medicine, PGIMER, Chandigarh, 160012 India
| | - Rayaz Ahmed
- Rajiv Gandhi Cancer Institute, New Delhi, India
| | | | | | | | - Sharat Damodar
- Mazumdar Shaw Medical Center, Narayana Health City, Bangalore, India
| | | | - Sunil Bhat
- Mazumdar Shaw Medical Center, Narayana Health City, Bangalore, India
| | | | | | - Velu Nair
- Comprehensive Blood and Cancer Center, Ahmedabad, India
| | | |
Collapse
|
47
|
Sharma A, Rastogi N, Chatterjee G, Kapoor R, Nivargi S, Kohli S, Misra R, Katewa S, Sachdeva A, Yadav SP. Outcomes of pediatric haematopoietic stem cell transplant: a decade long experience. Pediatric Hematology Oncology Journal 2019. [DOI: 10.1016/j.phoj.2019.08.140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
48
|
Kapoor R, Rastogi N, Chatterjee G, Sharma A, Yadav SP. Plasmodium Falciparum Induced Acquired Aplastic Anemia Successfully Treated with Antimalarials And Horse Antithymocyte Globulin. Pediatric Hematology Oncology Journal 2019. [DOI: 10.1016/j.phoj.2019.08.127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
49
|
Vidyadharan V, Tharayil HM, Dalwai SH, Kapoor R, Yadav SP, Kapil U, Bhadoria AS, Kumar J, Yadav A, Maria A, Shukla A. Correspondence. Indian Pediatr 2018. [DOI: 10.1007/s13312-018-1431-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
50
|
Sachdev R, Goel S, Rastogi N, Yadav SP, Mohapatra I. Unusual presentation of syncytial variant of nodular sclerosis classical Hodgkin's lymphoma presenting as unilateral lung mass in a 15-year-old child. Acta Oncol 2018; 57:1729-1732. [PMID: 30102114 DOI: 10.1080/0284186x.2018.1502465] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- Ritesh Sachdev
- Department of Pathology, Lab Medicine and Transfusion Medicine, Medanta – The Medicity Hospital, Gurgaon, India
| | - Shalini Goel
- Department of Pathology, Lab Medicine and Transfusion Medicine, Medanta – The Medicity Hospital, Gurgaon, India
| | - Neha Rastogi
- Department of Paediatric Oncology and Bone Marrow Transplantation, Medanta – The Medicity Hospital, Gurgaon, India
| | - Satya Prakash Yadav
- Department of Paediatric Oncology and Bone Marrow Transplantation, Medanta – The Medicity Hospital, Gurgaon, India
| | - Ishani Mohapatra
- Department of Pathology, Lab Medicine and Transfusion Medicine, Medanta – The Medicity Hospital, Gurgaon, India
| |
Collapse
|